Item Type | Name |
Concept
|
Evaluation Studies as Topic
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Drug Evaluation, Preclinical
|
Concept
|
Feasibility Studies
|
Concept
|
Mice, Transgenic
|
Concept
|
Models, Genetic
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Cohort Studies
|
Concept
|
Multicenter Studies as Topic
|
Concept
|
Proportional Hazards Models
|
Concept
|
Mice, Inbred DBA
|
Concept
|
Case-Control Studies
|
Concept
|
Mice, Knockout
|
Concept
|
Cross-Over Studies
|
Concept
|
Genetic Association Studies
|
Concept
|
Mice
|
Concept
|
Logistic Models
|
Concept
|
Disease Models, Animal
|
Concept
|
Follow-Up Studies
|
Concept
|
Longitudinal Studies
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Models, Biological
|
Concept
|
Models, Neurological
|
Concept
|
Prospective Studies
|
Concept
|
Retrospective Studies
|
Academic Article
|
Mixed vascular malformations of the brain: clinical and pathogenetic considerations.
|
Academic Article
|
Factors predisposing to clinical disability in patients with cavernous malformations of the brain.
|
Academic Article
|
Misdiagnosis of symptomatic cerebral aneurysm. Prevalence and correlation with outcome at four institutions.
|
Academic Article
|
Intracranial cavernous malformations: lesion behavior and management strategies.
|
Academic Article
|
Cerebral vascular malformations adjacent to sensorimotor and visual cortex. Functional magnetic resonance imaging studies before and after therapeutic intervention.
|
Academic Article
|
A comparison of the clinical profile of cavernous malformations with and without associated venous malformations.
|
Academic Article
|
Comparative localization of auditory comprehension by using functional magnetic resonance imaging and cortical stimulation.
|
Academic Article
|
Failure of the hypotensive provocative test during temporary balloon test occlusion of the internal carotid artery to predict delayed hemodynamic ischemia after therapeutic carotid occlusion.
|
Academic Article
|
Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience.
|
Academic Article
|
Impact of Guglielmi detachable coils on outcomes of patients with intracranial aneurysms treated by a multidisciplinary team at a single institution.
|
Academic Article
|
AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association.
|
Academic Article
|
Spine patient outcomes research trial.
|
Academic Article
|
Neuroendovascular interventions for intracranial posterior circulation disease via the transradial approach: technical case report.
|
Academic Article
|
How frequently should we follow small asymptomatic intracranial aneurysms?
|
Academic Article
|
Neurological deterioration in a patient with a spinal arteriovenous malformation following lumbar puncture. Case report.
|
Academic Article
|
Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models.
|
Academic Article
|
Second operation after the failure of previous resection for epilepsy.
|
Academic Article
|
Cavernous malformations of the basal ganglia and thalamus.
|
Academic Article
|
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
|
Academic Article
|
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
|
Academic Article
|
Prostacyclin in experimental ischemic models.
|
Academic Article
|
Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage.
|
Academic Article
|
Internal carotid artery occlusion for cavernous segment aneurysm.
|
Academic Article
|
Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program.
|
Academic Article
|
Periventricular lesions on MRI. Facts and theories.
|
Academic Article
|
From mutant mice to "vascular permeability therapy" in cavernous angiomas?
|
Academic Article
|
Treatment of acute focal cerebral ischemia with prostacyclin.
|
Academic Article
|
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.
|
Academic Article
|
Focal parenchymal lesions in transient ischemic attacks: correlation of computed tomography and magnetic resonance imaging.
|
Academic Article
|
Cerebral cavernous malformations: clinical insights from genetic studies.
|
Academic Article
|
Extracranial-intracranial bypass surgery: a critical analysis in light of the International Cooperative Study.
|
Academic Article
|
Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts.
|
Academic Article
|
Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage.
|
Academic Article
|
Genetic heterogeneity of inherited cerebral cavernous malformation.
|
Academic Article
|
Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage.
|
Academic Article
|
Extent of mesiobasal resection determines outcome after temporal lobectomy for intractable complex partial seizures.
|
Academic Article
|
Ruptured superior cerebellar artery aneurysm in a child with bilateral fibromuscular hyperplasia of the renal arteries: case report and review of the literature.
|
Academic Article
|
Retrograde suction decompression of giant paraclinoid aneurysms using a No. 7 French balloon-containing guide catheter. Technical note.
|
Academic Article
|
Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial.
|
Academic Article
|
Biology of vascular malformations of the brain.
|
Academic Article
|
Patch angioplasty in carotid endarterectomy. Advantages, concerns, and controversies.
|
Academic Article
|
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial.
|
Academic Article
|
Extent of resection in temporal lobectomy for epilepsy. I. Interobserver analysis and correlation with seizure outcome.
|
Academic Article
|
Natural history of recurrent seizures after resective surgery for epilepsy.
|
Academic Article
|
Intracarotid amobarbital procedure: I. Prediction of decreased modality-specific memory scores after temporal lobectomy.
|
Academic Article
|
Reoperation for intractable seizures.
|
Academic Article
|
Comparison and spacial correlation of interictal HMPAO-SPECT and FDG-PET in intractable temporal lobe epilepsy.
|
Academic Article
|
Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome).
|
Academic Article
|
Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography.
|
Academic Article
|
MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations.
|
Academic Article
|
Parenchymal perianeurysmal cystic changes in the brain: report of five cases.
|
Academic Article
|
What genes can teach us about human cerebrovascular malformations.
|
Academic Article
|
Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema.
|
Academic Article
|
Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association.
|
Academic Article
|
Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
|
Academic Article
|
Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.
|
Academic Article
|
Prediction of cognitive change as a function of preoperative ability status among temporal lobectomy patients seen at 6-month follow-up.
|
Academic Article
|
Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhage.
|
Academic Article
|
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
|
Academic Article
|
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.
|
Academic Article
|
Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease.
|
Academic Article
|
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
|
Academic Article
|
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
|
Academic Article
|
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
|
Academic Article
|
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
|
Academic Article
|
Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases.
|
Academic Article
|
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.
|
Academic Article
|
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.
|
Academic Article
|
Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.
|
Academic Article
|
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.
|
Academic Article
|
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.
|
Academic Article
|
Detection of microbleeds associated with sentinel headache using MRI quantitative susceptibility mapping: pilot study.
|
Academic Article
|
Phenotypic characterization of murine models of cerebral cavernous malformations.
|
Academic Article
|
Patients with cranial dural arteriovenous fistulas may benefit from expanded hypercoagulability and cancer screening.
|
Academic Article
|
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
|
Academic Article
|
Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).
|
Academic Article
|
Influence of Bleeding Pattern on Ischemic Lesions After Spontaneous Hypertensive Intracerebral Hemorrhage with Intraventricular Hemorrhage.
|
Academic Article
|
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.
|
Academic Article
|
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.
|
Academic Article
|
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.
|
Academic Article
|
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.
|
Academic Article
|
A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis.
|
Academic Article
|
Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome.
|
Academic Article
|
Biomarkers of cavernous angioma with symptomatic hemorrhage.
|
Academic Article
|
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease.
|
Academic Article
|
Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations.
|
Academic Article
|
Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.
|
Academic Article
|
Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
|
Academic Article
|
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican.
|
Academic Article
|
Novel Murine Models of Cerebral Cavernous Malformations.
|
Academic Article
|
A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage.
|
Academic Article
|
Cerebrovascular Complications in Early Survivors of Civilian Penetrating Brain Injury.
|
Academic Article
|
Propranolol inhibits cavernous vascular malformations by ß1 adrenergic receptor antagonism in animal models.
|
Academic Article
|
Temporal Evolution and Outcomes of Non-Traumatic Intracerebral Hemorrhage in Hospitalized Patients.
|
Academic Article
|
A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
|
Academic Article
|
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage.
|
Academic Article
|
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
|
Academic Article
|
Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.
|
Academic Article
|
Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage.
|
Academic Article
|
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.
|
Academic Article
|
Commentary: Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases.
|
Academic Article
|
Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned.
|
Academic Article
|
Post-Stroke Depression in Patients with Large Spontaneous Intracerebral Hemorrhage.
|
Academic Article
|
Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project.
|
Academic Article
|
Propranolol inhibits cavernous vascular malformations by ß1 adrenergic receptor antagonism in animal models.
|
Academic Article
|
Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis.
|
Academic Article
|
Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans.
|
Academic Article
|
Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease.
|
Academic Article
|
Evidence-based interconversion of the Glasgow Outcome and modified Rankin scales: pitfalls and best practices.
|
Academic Article
|
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
|
Concept
|
Observational Studies as Topic
|
Grant
|
Rock Inhibition as Therapy for Cerebral Cavernous Malformation
|
Grant
|
IMMUNE RESPONSE IN HUMAN CEREBRAL CAVERNOUS MALFORMATIONS
|
Grant
|
Biomarkers of Cerebral Cavernous Angioma with Symptomatic Hemorrhage (CASH)
|
Grant
|
Genesis and Progression of Cerebral Cavernous Malformations
|
Grant
|
Development of BA-1049 for treatment of cerebral cavernous malformation
|
Grant
|
BIOMARKERS OF BRAIN PERMEABILITY IN HUMAN CEREBRAL CAVERNOUS MALFORMATIONS
|
Academic Article
|
Impact of socioeconomics and race on clinical follow-up and trial enrollment and adherence in cerebral cavernous malformation.
|
Academic Article
|
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy.
|
Academic Article
|
mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice.
|
Academic Article
|
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling.
|
Academic Article
|
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome.
|